These are preliminary reports that have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information. For more information, please see our FAQs.
Shchelik_et_al_Light_Activated.pdf (7.36 MB)

Design, Synthesis, and Biological Evaluation of Light-Activated Antibiotics

submitted on 11.01.2021, 12:52 and posted on 12.01.2021, 08:12 by Inga S. Shchelik, Andrea Tomio, Karl Gademann

The spatial and temporal control of bioactivity of small molecules by light (photopharmacology) constitutes a promising approach for study of biological processes and ultimately for the treatment of diseases. In this study, we investigated two different ‘caged’ antibiotic classes that can undergo remote activation with UV-light at λ=365 nm, via the conjugation of deactivating and photocleavable units through a short synthetic sequence. The two widely used antibiotics vancomycin and cephalosporin were thus enhanced in their performance by rendering them photoresponsive and thus suppressing undesired off-site activity. The antimicrobial activity against Bacillus subtilis ATCC 6633, Staphylococcus aureus ATCC 29213, S. aureus ATCC 43300 (MRSA), Escherichia coli ATCC 25922, and Pseudomonas aeruginosa ATCC 27853 could be spatiotemporally controlled with light. Both molecular series displayed a good activity window. The vancomycin derivative displayed excellent values against Gram-positive strains after uncaging, and the next-generation caged cephalosporin derivative achieved good and broad activity against both Gram-positive and Gram-negative strains after photorelease.


Swiss National Science Foundation (SNSF, Grant No. 182043)

Mechanism-Based Design, Synthesis, Biological Evaluation, and Delivery of Next-Generation Antibiotics

Swiss National Science Foundation

Find out more...



Email Address of Submitting Author


University of Zurich



ORCID For Submitting Author


Declaration of Conflict of Interest

No conflict of interest